Which has the lower trailing P/E, ARQT or AVAH?

AVAH has the lower trailing P/E: ARQT trades at 116.82 and AVAH at 9.77. P/E is one valuation measure and does not by itself establish which business is cheaper.

Is ARQT or AVAH more profitable?

AVAH runs the higher net margin — ARQT at 6.15% versus AVAH at 10.56%.

How have ARQT and AVAH total returns compared?

Over the past 5 years, ARQT delivered -0.28% and AVAH delivered 9.75% annualized total return. Past performance doesn't predict future results.

Arcutis Biotherapeutics, Inc. (ARQT) vs Aveanna Healthcare Holdings Inc. (AVAH)

A side-by-side comparison of Arcutis Biotherapeutics, Inc. and Aveanna Healthcare Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARQT

Arcutis Biotherapeutics, Inc.

$3.05B

$24.36HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

AVAH

Aveanna Healthcare Holdings Inc.

$2.69B

$12.34HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

Total return — ARQT vs AVAH

growth of $100 · dividends reinvested · last 5y

ARQT -16.4% (-3.5%/yr)AVAH +3.1% (+0.6%/yr)AVAH compounded faster over this window

ARQT AVAH

ARQT vs AVAH: by the numbers

•ARQT is the larger company ($3.05B vs $2.69B market cap).
•AVAH trades at the lower trailing earnings multiple (9.77 vs 116.82 P/E), one valuation lens rather than an overall verdict.
•AVAH converts more revenue to profit (10.56% vs 6.15% net margin).

Metrics side by side

Valuation

Metric	ARQT	AVAH
P/E ratio	116.82	9.77
Forward P/E	48.99	14.98
P/S ratio	6.57	1.03
P/B ratio	13.81	9.35
EV / EBITDA	84.04	13.22
FCF yield	1.29%	5.90%

Profitability

Metric	ARQT	AVAH
Gross margin	91.14%	31.95%
Operating margin	-3.25%	11.12%
Net margin	6.15%	10.56%
ROE	12.93%	95.64%
ROIC	9.95%	15.45%

Growth (annualized)

Metric	ARQT	AVAH
Revenue CAGR (5Y)	N/A	9.65%
FCF CAGR (5Y)	N/A	58.99%
Total return CAGR (5Y)	-0.28%	9.75%

Frequently asked

Which has the lower trailing P/E, ARQT or AVAH?: AVAH has the lower trailing P/E: ARQT trades at 116.82 and AVAH at 9.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is ARQT or AVAH more profitable?: AVAH runs the higher net margin — ARQT at 6.15% versus AVAH at 10.56%.
How have ARQT and AVAH total returns compared?: Over the past 5 years, ARQT delivered -0.28% and AVAH delivered 9.75% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ARQT analysis Full AVAH analysis Interactive comparison tool

Dig into the metrics

Arcutis Biotherapeutics P/E ratio Aveanna Healthcare P/E ratio Arcutis Biotherapeutics ROE Aveanna Healthcare ROE Arcutis Biotherapeutics operating margin Aveanna Healthcare operating margin Arcutis Biotherapeutics revenue growth Aveanna Healthcare revenue growth Arcutis Biotherapeutics free cash flow Aveanna Healthcare free cash flow

Arcutis Biotherapeutics & Aveanna Healthcare appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.